Advertisement

Pathological Factors Affecting Outcomes in Oral Cancer

  • Eric R. CarlsonEmail author
  • J. Michael McCoy
Chapter

Abstract

Squamous cell carcinoma of the oral cavity represents an intriguing diagnosis with variable outcomes over the past 50 years of recorded observation. While our understanding of the pathogenesis and treatment of this disease has increased during this time, the prognosis of these cancers has demonstrated only slight improvement. To this end, many pathologic factors impacting the prognosis of patients with oral squamous cell carcinoma are recognized, including grade, depth of invasion, perineural invasion, positive margins, the histologic status of the cervical lymph nodes, and the presence of human papillomavirus. It is the purpose of this chapter to discuss these prognostic indices of oral squamous cell carcinoma while reporting on the international literature that assesses the role of adjuvant therapy when adverse features are identified that impact the patient’s prognosis.

Keywords

Histologic grade Depth of invasion Perineural invasion Margins Cervical lymph node metastases Extracapsular extension Human papillomavirus Bone invasion 

References

  1. 1.
    Wagner VP, Webber LP, Curra M, Klein IP, Meurer L, Carrad VC, Martins MD. Bryne’s grading system predicts poor disease-specific survival of oral squamous cell carcinoma: a comparative study among different histologic grading system. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123:688–96.PubMedCrossRefGoogle Scholar
  2. 2.
    Johnson NW, Amarashinghe HK, Qualliotine JR, Fakhry C. Epidemiology. In: Bell RB, Fernandes RP, Andersen PE, editors. Oral, head and neck oncology and reconstructive surgery. St. Louis, MO: Elsevier; 2018. p. 2–56.CrossRefGoogle Scholar
  3. 3.
    Duncan LD, Winkler M, Carlson ER, Heidel RE, Kang E, Webb DE. Prevalence of human papillomavirus in squamous cell carcinoma of the oral cavity with correlation of p16 immunohistochemistry and human papillomavirus polymerase chain reaction. J Oral Maxillofac Surg. 2013;71:1367–75.PubMedCrossRefGoogle Scholar
  4. 4.
    Vuity D, McMahon J, Takhiuddin S, Slinger C, McLellan D, Wales C, MacIver C, Thomson E, McCaul J, Hislop S, Lamb C, Stalker E, Young D. Is the 8th edition of the Union for International Cancer Control staging of oral cancer good enough? Br J Oral Maxillofac Surg. 2018;56:272–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma of the tongue and floor of mouth. Am J Surg. 1986;152:345–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC, Keum KC. Clinical outcomes for T1-2 N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol. 2010;5:1–7.CrossRefGoogle Scholar
  7. 7.
    Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and neck cancers – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.PubMedCrossRefGoogle Scholar
  8. 8.
    Elston CW, Ellis IOI. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Gleason DF. Classification of prostatic carcinoma. Cancer Chemother Rep. 1966;50:125–8.PubMedGoogle Scholar
  10. 10.
    Broders AC. Squamous cell epithelioma of the lip. JAMA. 1920;74:656–64.CrossRefGoogle Scholar
  11. 11.
    Barnes L, Eveson JW, Reichart P, Sidransky D. WHO classification of tumors, vol. 9. Lyon: IARC; 2005.Google Scholar
  12. 12.
    Muller S. Update from the 4th edition of the World Health Organization of head and neck tumours: tumours of the oral cavity and mobile tongue. Head Neck Pathol. 2017;11:33–40.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders’ grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18:432–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Jacobsson PA, Eneroth CM, Killander D, Moberger G, Martenson B. Histologic classification and grading of malignancy in carcinoma of the larynx (a pilot study). Acta Radiol Ther Phys Biol. 1973;12:1–8.CrossRefGoogle Scholar
  15. 15.
    Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinoma. J Dent Res. 1987;95:229–49.Google Scholar
  16. 16.
    Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166:375–81.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Sawazaki-Calone I, Rangel ALCA, Bueno AG, Morais CF, Nagai HM, Kunz RP, Souza RL, Rutkauskis L, Salo T, Almangush A, Coletta RD. The prognostic value of histopathological grading systems in oral squamous cell carcinomas. Oral Dis. 2015;21:755–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken M, Wang BY. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167–78.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Almangush A, Coletta RD, Bello IO, Bitu C, Keski-Santii H, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Tommola S, Soini Y, Kosma VM, Koivunen P, Kawalski LP, Nieminen P, Grenman R, Leivo I, Salo T. A simple novel prognostic model for early stage oral tongue cancer. Int J Oral Maxillofac Surg. 2015;44:143–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Tarsitano A, Tardio ML, Marchetti C. Impact of perineural invasion as independent prognostic factor for local and regional failure in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:221–8.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Chatzistefanou I, Lubek J, Markou K, Ord RA. The role of perineural invasion in treatment decisions for oral cancer patients: a review of the literature. J Cranio-Maxillofac Surg. 2017;45:821–5.CrossRefGoogle Scholar
  22. 22.
    Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379–91.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Cracchiolo JR, Xu B, Migliacci JC, Katabi N, Pfister DG, Lee NY, Patel SG, Ghossein RA, Wong RJ. Patterns of recurrence in oral tongue cancer with perineural invasion. Head Neck. 2018;40:1287–95.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines). Head and neck cancers. Version 2.2018 – 20 Jun 2018. www.nccn.org. Accessed 14 Jul 2018.
  25. 25.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med. 2004;350:1945–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Magliocca KR. Surgical margins. The perspective of pathology. Oral Maxillofac Surg Clin North Am. 2017;29:367–75.PubMedCrossRefGoogle Scholar
  27. 27.
    Weinstock YE, Allava I, Dierks EJ. Ptifalls in determining head and neck surgical margins. Oral Maxillofac Surg Clin North Am. 2014;26:151–62.PubMedCrossRefGoogle Scholar
  28. 28.
    Shapiro M, Salama A. Margin analysis. Squamous cell carcinoma of the oral cavity. Oral Maxillofac Surg Clin North Am. 2017;29:259–67.PubMedCrossRefGoogle Scholar
  29. 29.
    Dillon JK, Brown CB, McDonald TM, Ludwig DC, Clark PJ, Leroux BG, Futran ND. How does the close surgical margin impact recurrence and survival when treating oral squamous cell carcinoma? J Oral Maxillofac Surg. 2015;73:1182–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Byers RM, Bland KI, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous cell carcinoma of the head and neck. Am J Surg. 1978;136:525–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Johnson RE, Sigman JD, Funk GF, Robinson RA, Hoffman HT. Quantification of surgical margin shrinkage in the oral cavity. Head Neck. 1997;19:281–6.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Mistry RC, Qureshi SS, Kumaran C. Post-resection mucosal margin shrinkage in oral cancer: quantification and significance. J Surg Oncol. 2005;91:131–3.PubMedCrossRefGoogle Scholar
  33. 33.
    Cheng A, Cox D, Schmidt BL. Oral squamous cell carcinoma margin discrepancy after resection and pathologic processing. J Oral Maxillofac Surg. 2008;66:523–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Ord RA, Aisner S. Accuracy of frozen sections in assessing margins in oral cancer resection. J Oral Maxillofac Surg. 1997;55:663–9.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Ellis OG, David MC, Park DJ, Batstone MD. High-volume surgeons deliver larger surgical margins in oral cavity cancer. J Oral Maxillofac Surg. 2016;74:1466–72.PubMedCrossRefGoogle Scholar
  36. 36.
    Edwards SP. Margin analysis – has free tissue transfer improved oncologic outcomes for oral squamous cell carcinoma? Oral Maxillofac Surg Clin North Am. 2017;29:377–81.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med. 1995;332:429–35.PubMedCrossRefGoogle Scholar
  38. 38.
    Liu SA, Wang CC, Jiang RS, Wang WY, Lin JC. Genetic analysis of surgical margins in oral cavity cancer. Br J Surg. 2018;105:e142–9.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    de Carvalho AC, Kowalski LP, Campos AHJF, Soares FA, Carvalho AL, Vettore AL. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol. 2012;48:240–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Ferris RL, Xi L, Raja S, Hung JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, Godfrey TE. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res. 2005;65:2147–56.PubMedCrossRefGoogle Scholar
  41. 41.
    Brockhoff HC, Kim RY, Braun TM, Skouteris C, Helman JI, Ward BB. Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma. Head Neck. 2017;39:974–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    de Matos LL, Manfro G, dos Santos RV, Stabenow E, de Mello ES, Alves VAF, Pinto FR, Kulesar MAV, Brandao LG, Cernea CR. Tumor thickness as a predictive factor of lymph node metastasis and disease recurrence in T1N0 and T2N0 squamous cell carcinoma of the oral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:209–17.PubMedCrossRefGoogle Scholar
  43. 43.
    Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.PubMedCrossRefGoogle Scholar
  44. 44.
    Masood MH, Farquhar DR, Vanleer JP, Patel SN, Hackman TG. Depth of invasion on pathological outcomes in clinical low-stage oral tongue cancer patients. Oral Dis. 2018;24:1198–203.PubMedCrossRefGoogle Scholar
  45. 45.
    Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg. 1977;134:450–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Ghadjar P, Schreier-Facklam H, Grater R, Evers C, Simcock M, Geretschlager A, Blumstein NM, Zbaren P, Zimmer Y, Wilkens L, Aebersold DM. Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:1127–32.PubMedCrossRefGoogle Scholar
  47. 47.
    D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373:521–9.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Kuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL. Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity. Cancer. 2016;122:3624–31.PubMedCrossRefGoogle Scholar
  49. 49.
    Shaw RJ, Brown J, Etti T, Risk JM. Prognostic factors in oral, oropharyngeal, and salivary gland cancer. In: Brennan PA, Schliephake H, Ghali GE, Cascarini L, editors. Maxillofacial surgery. 3rd ed. St. Louis, MO: Elsevier; 2017. p. 257–74.CrossRefGoogle Scholar
  50. 50.
    Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States 2009–2010. JAMA. 2012;307:693–703.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, Wiley DJ, Minkoff H, Reddy S, Stammer EE, Gillison ML, D’Souza G. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at risk HIV-negative adults. Cancer Epidemiol Biomark Prev. 2012;21:122–33.CrossRefGoogle Scholar
  52. 52.
    Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmeron JJ, Lazcano-Ponce E, Giulliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877–87.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev. 2005;14:467–75.CrossRefGoogle Scholar
  54. 54.
    Li C, Lin J, Men Y, Yang W, Mi F, Li L. Does medullary versus cortical invasion of the mandible affect prognosis in patients with oral squamous cell carcinoma? J Oral Maxillofac Surg. 2017;75:403–15.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Petrovic I, Montero PH, Migilacci MC, Palmer FL, Ganly I, Patel SG, Shah JP. Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity. J Craniomaxillofac Surg. 2017;45:252–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Adel M, Kao HK, Hsu CL, Huang JJ, Lee LY, Huang Y, Browne T, Tsang NM, Chang YL, Chang KP. Evaluation of lymphatic and vascular invasion in relation to clinicopathological factors and treatment outcome in oral cavity squamous cell carcinoma. Medicine. 2015;94:e1510.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Oral and Maxillofacial SurgeryUniversity of Tennessee Graduate School of MedicineKnoxvilleUSA
  2. 2.Oral/Head and Neck Oncologic Surgery Fellowship ProgramUniversity of Tennessee Cancer InstituteKnoxvilleUSA
  3. 3.Oral and Maxillofacial Surgery Residency Program, Department of Oral and Maxillofacial SurgeryUniversity of Tennessee Graduate School of MedicineKnoxvilleUSA
  4. 4.Oral and Maxillofacial Surgery Residency Program, Department of Oral and Maxillofacial SurgeryUniversity of Tennessee Graduate School of MedicineKnoxvilleUSA
  5. 5.Department of PathologyUniversity of Tennessee Graduate School of MedicineKnoxvilleUSA
  6. 6.Department of RadiologyUniversity of Tennessee Graduate School of MedicineKnoxvilleUSA

Personalised recommendations